Sulfated archaeosomes as mucosal vaccine adjuvants

WO2026115354A1PCT designated stage Publication Date: 2026-06-04NAT RES COUNCIL OF CANADA

Patent Information

Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
NAT RES COUNCIL OF CANADA
Filing Date
2025-11-07
Publication Date
2026-06-04

Smart Images

  • Figure IB2025061404_04062026_PF_FP_ABST
    Figure IB2025061404_04062026_PF_FP_ABST
Patent Text Reader

Abstract

Provided is an adjuvant for mucosal vaccines comprising a sulfated archeosome comprising a sulfated lactosyl archaeol. The glycoarchaeol may be present as a pharmaceutically acceptable salt. The adjuvant may be comprised together with an antigen in a vaccine composition, which may be for use to induce an immune response in a subject, in particular an antigen-specific mucosal immune response. The vaccine composition may further elicit an immune response that also comprises a cell-mediated response and / or a humoral response.
Need to check novelty before this filing date? Find Prior Art